"Icon Cancer Centre Chermside offers a full range of cancer treatments and blood disorder treatments. The centre is located within Chermside Medical Complex. Treatment options include chemotherapy, immunotherapy, targeted therapies, apheresis, treatment for blood disorders and a lymphoedema management program. Icon has access to scalp cooling systems, clinical trials, pharmacy and allied health services. There is no wait list, ensuring patients receive immediate access to consultation and treatment. The centre has a team of caring medical oncologists, haematologists, oncology nurses and administrative staff who are committed to providing personalised care to patients and their loved ones. Free undercover parking is available on-site."

During the past decade, Icon Cancer Care Chermside conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 8 clinical trials were completed, i.e. on average, 88.9% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Icon Cancer Care Chermside" #1 collaborator was "Astellas Pharma Inc" with 6 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 5 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Medivation, Inc." with 1 trials as a collaborator and "Myriad Genetics, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Icon Cancer Care Chermside" are "Prostate Cancer" (5 trials), "Cancer of the Prostate" (2 trials), "Breast Cancer" (1 trials), "Castration-Resistant Prostate Cancer" (1 trials) and "Hormone Sensitive Prostate Cancer" (1 trials). Many other conditions were trialed in "Icon Cancer Care Chermside" in a lesser frequency.

Most popular intervention types in "Icon Cancer Care Chermside" are "Drug" (12 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Enzalutamide" (5 trials), "Placebo" (4 trials), "Abiraterone" (1 trials), "Avelumab" (1 trials) and "Azacitidine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Icon Cancer Care Chermside" are 7 trials for "Male" genders, 4 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Icon Cancer Care Chermside". undefined are not yet recruiting, 1 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Icon Cancer Care Chermside, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Icon Cancer Care Chermside, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".